Literature DB >> 14584038

Sphingosine 1-phosphate induces cell contraction via calcium-independent/Rho-dependent pathways in undifferentiated skeletal muscle cells.

L Formigli1, E Meacci, M Vassalli, D Nosi, F Quercioli, B Tiribilli, A Tani, R Squecco, F Francini, P Bruni, S Zecchi Orlandini.   

Abstract

We have previously shown that sphingosine 1-phosphate (S1P) can induce intracellular Ca(2+) mobilization and cell contraction in C2C12 myoblasts and that the two phenomena are temporally unrelated. Although Ca(2+)-independent mechanisms of cell contraction have been the focus of numerous studies on Ca(2+) sensitization of smooth muscle, comparatively less studies have focused on the role that these mechanisms play in the regulation of skeletal muscle contractility. Phosphorylation and activation of myosin by Rho-dependent kinase mediate most of Ca(2+)-independent contractile responses. In the present study, we examined the potential role of Rho/Rho-kinase cascade activation in S1P-induced C2C12 cell contraction. First, we showed that depletion of Ca(2+), by pre-treatment with BAPTA, did not affect S1P-induced myoblastic contractility, whereas it abolished S1P-induced Ca(2+) transients. These results correlated with the absence of troponin C and with the immature cytoskeletal organization of these cells. Experimental evidence demonstrating the involvement of Rho pathway in S1P-stimulated myoblast contraction included: the activation/translocation of RhoA to the membrane in response to agonist-stimulation in cells depleted of Ca(2+) and the inhibition of dynamic changes of the actin cytoskeleton in cells where Rho functions had been inhibited either by overexpression of RhoGDI, a physiological inhibitor of GDP dissociation from Rho proteins, or by pretreatment with Y-27632, a specific Rho kinase inhibitor. Contribution of protein kinase C in this cytoskeletal rearrangement was also evaluated. However, the pretreatment with Gö6976 or rottlerin, specific inhibitors of PKC alpha and PKC delta, respectively, failed to inhibit the agonist-induced myoblastic contraction. Single particle tracking of G-actin fluorescent probe was performed to statistically evaluate actin cytoskeletal dynamics in response to S1P. Stimulation with S1P was also able to increase the phosphorylation level of myosin light chain II. In conclusion, our results strongly suggest that Ca(2+)-independent/Rho-Rho kinase-dependent pathways may exert an important role in S1P-induced myoblastic cell contraction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14584038     DOI: 10.1002/jcp.10366

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

1.  MLCK-independent phosphorylation of MLC20 and its regulation by MAP kinase pathway in human bladder smooth muscle cells.

Authors:  Maoxian Deng; Wei Ding; Xuewen Min; Ying Xia
Journal:  Cytoskeleton (Hoboken)       Date:  2010-08-18

2.  Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor.

Authors:  Elena Rapizzi; Maria Letizia Taddei; Tania Fiaschi; Chiara Donati; Paola Bruni; Paola Chiarugi
Journal:  Cell Mol Life Sci       Date:  2009-08-07       Impact factor: 9.261

Review 3.  Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?

Authors:  Chiara Simone; Agnese Ramirez; Monica Bucchia; Paola Rinchetti; Hardy Rideout; Dimitra Papadimitriou; Diane B Re; Stefania Corti
Journal:  Cell Mol Life Sci       Date:  2015-12-18       Impact factor: 9.261

4.  Controlled heterogeneous stem cell differentiation on a shape memory hydrogel surface.

Authors:  Yanjiao Han; Tao Bai; Wenguang Liu
Journal:  Sci Rep       Date:  2014-07-28       Impact factor: 4.379

Review 5.  ROCK inhibition as a therapy for spinal muscular atrophy: understanding the repercussions on multiple cellular targets.

Authors:  Emmanuelle Coque; Cédric Raoul; Mélissa Bowerman
Journal:  Front Neurosci       Date:  2014-08-28       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.